Effect of amla in honey in the correction of anemia in pregnancy

Effect of supplementation of Amla (Emblica officinalis) in Honey on the hematological profile and iron homeostasis in anemic pregnancy: An open -labelled clinical trial. - nil

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/04/066244

Enrollment

Registered

2024-04-24

Start date

Unknown

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D508- Other iron deficiency anemias

Interventions

Intervention1: Amla(Emblica officinalis) soaked in honey: The intervention group will be provided supplementation of two amla (Emblica officinalis) FSSAI certified, soaked in honey (one in the morning

Eligibility

Inclusion criteria

Inclusion criteria: Hemoglobin level between 9 to 11 milligram per deciliter Age between 18 to 35 years 1st and 2nd trimester of pregnancy On oral iron therapy

Exclusion criteria

Exclusion criteria: Patients with a history of anemia due to any other conditions like bleeding piles cardiac or renal or liver disorders Diabetes Mellitus Hypertension Pregnancy induced complications like hyperemesis gravidarum antepartum hemorrhage pre eclampsia eclampsia GDM jaundice Patients with a history of drug abuse Patients with a history of allergy to amla or honey

Design outcomes

Primary

Measure	Time frame
Hemoglobin level Hematological profile Indices of iron homeostasisTimepoint: 45 days	—

Secondary

Measure	Time frame
Quality of lifeTimepoint: 45 days	—

Countries

India

Contacts

Public ContactSanthossiniS

JIPMER

zacbobby@yahoo.com9443602996

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026